Resources

Model overview

Considerations for developing and deploying cost and economic impact models in the elimination/control of 5 PCT NTDs

The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.
USAID's Act to End NTDs | West's Kisito Ogoussan

Applying a quality improvement model to neglected tropical diseases program implementation: supporting programs in identifying keys for sustaining operations

West African neglected tropical diseases (NTD) programs have made great progress toward the elimination/control of NTDs amenable to preventive chemotherapy. However, some districts have failed impact surveys—notably for lymphatic filariasis and trachoma—due to implementation inadequacies, despite reporting good mass treatment coverage. A quality improvement framework has been initiated to strengthen country program interventions and address issues that hinder their ability to achieve the World Health Organization NTD road map elimination/control goals.  The workshop aims to present an innovative model for improving implementation and discuss ideas, strategies, and plans for initiating quality improvement (QI) activities. Experiences from Ghana and Sierra Leone in the design and implementation of the QI model will be shared. 
Colleagues at USAID's LF TAS Workshop

Lymphatic Filariasis Operational Research Updates from NTDSC

Updates on operational research for lymphatic filariasis were shared from the Neglected Tropical Diseases Support Center on January 16, 2020.
The Carter Center's Emily Griswold

Improving Mass Drug Administration Tools

The Carter Center's Emily Griswold presents on improving mass drug administration tools on January 16, 2020.
RTI's Clara Burgert and Diana Lu

High Quality Disease-Specific Assessment Implementation and Electronic Data Collection

RTI's Clara Burgert and Diana Lu talk about how to ensure high-quality standardized surveys on January 16, 2020.
RTI's Clara Burgert

Investigating and Responding to LF Survey Failures

RTI's Clara Burgert leads a panel discussion on how to investigate and respond to LF survey failures on January 15, 2020.
Abdel Direny, IMA Worldhealth

Transmission Assessment Survey Preparation and Supervision

IMA World Health's Abdel Direny, MD, MPH, presented guidance for transmission assessment survey preparation and supervision on January 15, 2020.
Group Photo of USAID's Act to End NTDs l West January 2020 LF TAS Workshop Participants

Tanzania Transmission Assessment Survey Experience

IMA Tanzania's Andreas Nshala presents Tanzania's experience with conducting transmission assessment surveys for lymphatic filariasis on January 15, 2020.
Conference attendees learn how to use the WHO LF diagnostics feedback form

WHO Lymphatic Filariasis Diagnostic Feedback Form (English)

WHO form to provide feedback on invalid lymphatic filariasis diagnostic tests (English version).
Caitlin Worrell, CDC

Filariasis Test Strip Quality and Reporting

The US Center for Disease Control and Prevention's Caitlin Worrell discussed filariasis test strip quality as a diagnostic tool and reporting issues with the tool on January 14, 2020.